Safety and Efficacy of Glecaprevir Pibrentasvir in Chronic Kidney Disease, Compensated Cirrhosis and Non-Cirrhosis. CDF 2025, 54 (3), 883-894. https://doi.org/10.48047/pe0m6t61.